Journal of Clinical Oncology, Vol 15, 1294-1301, Copyright © 1997 by American Society of Clinical Oncology

ARTICLES

Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation

C Leighton, B Fisher, G Bauman, S Depiero, L Stitt, D MacDonald and G Cairncross
Department of Oncology, University of Western Ontario, London, Canada.

PURPOSE: To review the outcomes of patients with low-grade glioma diagnosed by modern imaging and treated at a center where postponing radiotherapy was common practice. METHODS: We reviewed the records of patients (age > or = 18 years) with pathologically confirmed supratentorial low-grade fibrillary astrocytoma, oligodendroglioma, and mixed glioma treated at a regional cancer center in Canada between 1979 and 1995. RESULTS: Median survival for the entire group (N = 167; mean age 40.6 years) was 10.5 years with 5- and 10-year survival rates of 72% and 50%, respectively. Median progression-free survival was 4.9 years with 5- and 10-year progression-free rates of 50% and 12%, respectively. Overall and progression-free survivals were longer for patients with an oligodendroglioma or mixed glioma than with astrocytoma (median 13 v 7.5 years, P = .003; progression-free 5.6 v 4.4 years, p = .054). Age at diagnosis < or = 40 years, seizures at presentation, minimal residual tumor after surgery, Karnofsky performance status > or = 70, and oligodendroglioma or mixed glioma pathology were associated with significantly longer median survival on univariate and multivariate analyses. Radiotherapy deferred until tumor progression (v immediate radiotherapy) was associated with longer survival on univariate analysis, but an imbalance in other variables accounted for this advantage such that timing of radiotherapy was not an independent (favorable or adverse) prognostic factor on multivariate analysis. CONCLUSION: Patients with low-grade glioma diagnosed by modern imaging can be expected to live a long time; timing of radiotherapy may be a less important determinant of survival than nontreatment variables and residual tumor bulk.

This article has been cited by other articles:

				S. Kesari, D. Schiff, J. Drappatz, D. LaFrankie, L. Doherty, E. A. Macklin, A. Muzikansky, S. Santagata, K. L. Ligon, A. D. Norden, et al. Phase II Study of Protracted Daily Temozolomide for Low-Grade Gliomas in Adults Clin. Cancer Res., January 1, 2009; 15(1): 330 - 337. [Abstract] [Full Text] [PDF]

				J. S. Smith, E. F. Chang, K. R. Lamborn, S. M. Chang, M. D. Prados, S. Cha, T. Tihan, S. VandenBerg, M. W. McDermott, and M. S. Berger Role of Extent of Resection in the Long-Term Outcome of Low-Grade Hemispheric Gliomas J. Clin. Oncol., March 10, 2008; 26(8): 1338 - 1345. [Abstract] [Full Text] [PDF]

				D. Hagerstrand, A. Smits, A. Eriksson, S. Sigurdardottir, T. Olofsson, M. Hartman, M. Nister, H. Kalimo, and A. Ostman Gene expression analyses of grade II gliomas and identification of rPTP{beta}/{zeta} as a candidate oligodendroglioma marker Neuro-oncol, February 1, 2008; 10(1): 2 - 9. [Abstract] [Full Text] [PDF]

				N. Sanai, Z. Mirzadeh, and M. S. Berger Functional Outcome after Language Mapping for Glioma Resection N. Engl. J. Med., January 3, 2008; 358(1): 18 - 27. [Abstract] [Full Text] [PDF]

				I. Bosma, L. Douw, F. Bartolomei, J. J. Heimans, B. W. van Dijk, T. J. Postma, C. J. Stam, J. C. Reijneveld, and M. Klein Synchronized brain activity and neurocognitive function in patients with low-grade glioma: A magnetoencephalography study Neuro-oncol, January 1, 2008; 10(5): 734 - 744. [Abstract] [Full Text] [PDF]

				D. Schiff, P. D. Brown, and C. Giannini Outcome in adult low-grade glioma: The impact of prognostic factors and treatment Neurology, September 25, 2007; 69(13): 1366 - 1373. [Abstract] [Full Text] [PDF]

				W. Chen Clinical Applications of PET in Brain Tumors J. Nucl. Med., September 1, 2007; 48(9): 1468 - 1481. [Abstract] [Full Text] [PDF]

				J. T. Grier and T. Batchelor Low-grade gliomas in adults. Oncologist, June 1, 2006; 11(6): 681 - 693. [Abstract] [Full Text] [PDF]

				F. F. Lang and M. R. Gilbert Diffusely Infiltrative Low-Grade Gliomas in Adults J. Clin. Oncol., March 10, 2006; 24(8): 1236 - 1245. [Abstract] [Full Text] [PDF]

				M. Law, S. Oh, J. S. Babb, E. Wang, M. Inglese, D. Zagzag, E. A. Knopp, and G. Johnson Low-Grade Gliomas: Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging--Prediction of Patient Clinical Response Radiology, February 1, 2006; 238(2): 658 - 667. [Abstract] [Full Text] [PDF]

				S-A Yeh, J-T Ho, C-C Lui, Y-J Huang, C-Y Hsiung, and E-Y Huang Treatment outcomes and prognostic factors in patients with supratentorial low-grade gliomas Br. J. Radiol., March 1, 2005; 78(927): 230 - 235. [Abstract] [Full Text] [PDF]

				P. D. Brown, J. T. Wald, M. W. McDermott, G. S. Baumann, and T. F. Cloughesy Oncodiagnosis panel: 2002. Optic nerve glioma or optic nerve meningioma. RadioGraphics, November 1, 2003; 23(6): 1591 - 1611. [Full Text] [PDF]

				P. D. Brown, J. C. Buckner, J. H. Uhm, and E. G. Shaw The neurocognitive effects of radiation in adult low-grade glioma patients Neuro-oncol, July 1, 2003; 5(3): 161 - 167. [Abstract] [PDF]

				P. D. Brown, J. C. Buckner, J. R. O'Fallon, N. L. Iturria, C. A. Brown, B. P. O'Neill, B. W. Scheithauer, R. P. Dinapoli, R. M. Arusell, W. J. Curran, et al. Effects of Radiotherapy on Cognitive Function in Patients With Low-Grade Glioma Measured by the Folstein Mini-Mental State Examination J. Clin. Oncol., July 1, 2003; 21(13): 2519 - 2524. [Abstract] [Full Text] [PDF]

				M. van den Bent, O.-L. Chinot, and J. G. Cairncross Recent developments in the molecular characterization and treatment of oligodendroglial tumors Neuro-oncol, April 1, 2003; 5(2): 128 - 138. [Abstract] [PDF]

				J. A. Quinn, D. A. Reardon, A. H. Friedman, J. N. Rich, J. H. Sampson, J. M. Provenzale, R. E. McLendon, S. Gururangan, D. D. Bigner, J. E. Herndon II, et al. Phase II Trial of Temozolomide in Patients With Progressive Low-Grade Glioma J. Clin. Oncol., February 15, 2003; 21(4): 646 - 651. [Abstract] [Full Text] [PDF]

				J. Huang, L. Barbera, M. Brouwers, G. Browman, and W. J. Mackillop Does Delay in Starting Treatment Affect the Outcomes of Radiotherapy? A Systematic Review J. Clin. Oncol., February 1, 2003; 21(3): 555 - 563. [Abstract] [Full Text] [PDF]

				F. Pignatti, M. van den Bent, D. Curran, C. Debruyne, R. Sylvester, P. Therasse, D. Afra, P. Cornu, M. Bolla, C. Vecht, et al. Prognostic Factors for Survival in Adult Patients With Cerebral Low-Grade Glioma J. Clin. Oncol., April 15, 2002; 20(8): 2076 - 2084. [Abstract] [Full Text] [PDF]

				S. Kunwar, G. Mohapatra, A. Bollen, K. R. Lamborn, M. Prados, and B. G. Feuerstein Genetic Subgroups of Anaplastic Astrocytomas Correlate with Patient Age and Survival Cancer Res., October 1, 2001; 61(20): 7683 - 7688. [Abstract] [Full Text] [PDF]

				J. S. Smith, I. Tachibana, S. M. Passe, B. K. Huntley, T. J. Borell, N. Iturria, J. R. O'Fallon, P. L. Schaefer, B. W. Scheithauer, C. D. James, et al. PTEN Mutation, EGFR Amplification, and Outcome in Patients With Anaplastic Astrocytoma and Glioblastoma Multiforme J Natl Cancer Inst, August 15, 2001; 93(16): 1246 - 1256. [Abstract] [Full Text] [PDF]

				K. Peterson and L. M. DeAngelis Weighing the benefits and risks of radiation therapy for low-grade glioma Neurology, May 22, 2001; 56(10): 1255 - 1256. [Full Text] [PDF]

				J. D. Olson, E. Riedel, and L. M. DeAngelis Long-term outcome of low-grade oligodendroglioma and mixed glioma Neurology, April 11, 2000; 54(7): 1442 - 1448. [Abstract] [Full Text] [PDF]

				U Roelcke, K von Ammon, O Hausmann, D L Kaech, W Vanloffeld, H Landolt, J A Rem, O Gratzl, E W Radü, and K L Leenders Operated low grade astrocytomas: a long term PET study on the effect of radiotherapy J. Neurol. Neurosurg. Psychiatry, May 1, 1999; 66(5): 644 - 647. [Abstract] [Full Text]

				N. A. Paleologos and J. G. Cairncross Treatment of oligodendroglioma: An update Neuro-oncol, January 1, 1999; 1(1): 61 - 68. [Abstract] [PDF]